PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Precision and Future Medicine10.23838/pfm.2020.0015620215113-20Blood glucose, antidiabetic drugs, and risk of strokeMeng Lee, Bruce Ovbiagelehttp://pfmjournal.org/upload/pdf/pfm-2020-00156.pdf, http://pfmjournal.org/journal/view.php?doi=10.23838/pfm.2020.00156, http://pfmjournal.org/upload/pdf/pfm-2020-00156.pdf
Diabetic Medicine10.1002/(sici)1096-9136(1998120)15:4+3.0.co;2-t199815S4S28-S36Repaglinide – prandial glucose regulator: a new class of oral antidiabetic drugsDavid R. Owenshttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F%28SICI%291096-9136%281998120%2915%3A4%2B%3CS28%3A%3AAID-DIA748%3E3.0.CO%3B2-T, http://onlinelibrary.wiley.com/wol1/doi/10.1002/(SICI)1096-9136(1998120)15:4+3.0.CO;2-T/fullpdf
Engineering Drug Delivery Systems10.1016/b978-0-08-102548-2.00009-32020203-228Glucose-sensitive materials for delivery of antidiabetic drugsMaria Saeed, Amr Elshaerhttps://api.elsevier.com/content/article/PII:B9780081025482000093?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B9780081025482000093?httpAccept=text/plain
Cardiovascular Drugs and Therapy10.1007/s10557-014-6522-02014284331-334Sodium Glucose Co-transporter 2 (SGLT2) Inhibitors: New among Antidiabetic DrugsL. H. Opiehttp://link.springer.com/content/pdf/10.1007/s10557-014-6522-0.pdf, http://link.springer.com/article/10.1007/s10557-014-6522-0/fulltext.html, http://link.springer.com/content/pdf/10.1007/s10557-014-6522-0
Acta Medica Scandinavica10.1111/j.0954-6820.1958.tb10327.x2009160167-74Effect of Oral Antidiabetic Drugs on Blood-Sugar and Inorganic Phosphate Curves in Oral and Intravenous Glucose-Tolerance Tests.1S. ESKJAER JENSEN, K. LUNDBAEK, BENT MØLLER, O. J. RAFAELSENhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.0954-6820.1958.tb10327.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.0954-6820.1958.tb10327.x/fullpdf
European Journal of Internal Medicine10.1016/j.ejim.2017.09.0192018481-5Antidiabetic drugs and stroke risk. Current evidenceLuis Castilla-Guerra, María del Carmen Fernandez-Moreno, David Leon-Jimenez, Eduardo Carmona-Nimohttps://api.elsevier.com/content/article/PII:S0953620517303680?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0953620517303680?httpAccept=text/plain
Drug Discovery and Evaluation: Pharmacological Assays10.1007/978-3-642-27728-3_65-120151-39Measurement of Blood Glucose-Lowering and Antidiabetic ActivityGünter Müllerhttp://link.springer.com/content/pdf/10.1007/978-3-642-27728-3_65-1
Journal of Korean Diabetes10.4093/jkd.2011.12.3.1292011123129Clinical Trial for Antidiabetic Drugs: FDA Guidance for Diabetes Mellitus-Evaluation of Cardiovascular Risk in New Antidiabetic TherapiesMoonsuk Namhttps://synapse.koreamed.org/DOIx.php?id=10.4093/jkd.2011.12.3.129, https://synapse.koreamed.org/pdf/10.4093/jkd.2011.12.3.129, https://e-jkd.org/DOIx.php?id=10.4093/jkd.2011.12.3.129
Diabetic Medicine10.1002/(sici)1096-9136(1998120)15:4+3.3.co;2-k199815S4S28-S36Repaglinide – prandial glucose regulator: a new class of oral antidiabetic drugsDavid R. Owenshttp://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F(SICI)1096-9136(1998120)15:4+%3CS28::AID-DIA748%3E3.3.CO;2-K, https://onlinelibrary.wiley.com/doi/full/10.1002/(SICI)1096-9136(1998120)15:4+%3CS28::AID-DIA748%3E3.3.CO;2-K
Meyler's Side Effects of Drugs10.1016/b978-0-444-53717-1.00395-420161026-1027Blood glucose metershttps://api.elsevier.com/content/article/PII:B9780444537171003954?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B9780444537171003954?httpAccept=text/plain